2Seventy Bio Inc: 2Seventy and Bristol Myers Squibb Discontinue Enrollment in Phase 3 Karmma-9 Study
2Seventy Bio公司:2Seventy和百時美施貴寶終止進行第3階段Karmma-9研究的招募
2Seventy Bio Inc: 2Seventy and Bristol Myers Squibb Discontinue Enrollment in Phase 3 Karmma-9 Study
2Seventy Bio公司:2Seventy和百時美施貴寶終止進行第3階段Karmma-9研究的招募
譯文內容由第三人軟體翻譯。